There’s an appetite to develop research relationship with Brussels, but agreeing terms is ‘a long-haul game’ says James Whisstock, scientific head of the European Molecular Biology Laboratory’s base in Australia
Science|Business is canvassing views on the big research priorities for the next term of the EU, from 2019 to 2024. Here, six policy experts discuss the most pressing items on the EU’s to-do list for health
New report shows how long term investment in novel products like cell and gene therapies is beginning to bear fruit. The concern now is the price of these products and ensuring patients get access
Chris Skidmore hopes EU will offer UK better exit terms after sensing 'paradigm shift' in Brussels position, following offer to extend grant funding beyond a no-deal Brexit
G20 statement marks first international agreement on how artificial intelligence should work – but also shows deep divisions between US, EU, Japan, China and Canada on the way forward
The European Commission wants to cut the number of industrial R&D partnerships from 120 now, to fewer than 50 in the next research programme, Horizon Europe. At a roundtable organised by Science|Business experts discussed how to ensure this increases impact without losing focus
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.